We published utilization result announcement.
07.23.2026
We have published a study of patients with heterozygous familial hypercholesterolaemia to assess the feasibility of developing
paediatric treatments for hypercholesterolaemia.
We have published a survey of paediatric patients with generalised myasthenia gravis regarding the feasibility of developing
subcutaneous formulations for children.